Key result
The Multidimensional Prognostic Index predicted 30-day mortality in older heart failure patients (AUC 0.83 in men, 0.80 in women), outperforming NYHA, EFFECT, and ADHERE scores.
Why the study?
Does the Multidimensional Prognostic Index (MPI) predict short-term mortality better than traditional risk scores in older patients with heart failure?
Cohort (n=376)
Does the Multidimensional Prognostic Index (MPI) predict short-term mortality better than traditional risk scores in older patients with heart failure?
The Multidimensional Prognostic Index (MPI) is a useful tool for estimating 1-month mortality risk in older patients with heart failure, showing better discrimination than traditional heart failure risk scores.
Authors
No takes yet. Share an insight, caveat, or question.
May aid short-term risk stratification in older HF; leaves open prospective validation before practice change.
Pilotto et al. (2009) conducted a cohort in heart failure (n=376). Multidimensional Prognostic Index (MPI) vs. Other risk scores (NYHA, EFFECT, ADHERE) was evaluated on 30-day mortality. The Multidimensional Prognostic Index predicted 30-day mortality in older heart failure patients (AUC 0.83 in men, 0.80 in women), outperforming NYHA, EFFECT, and ADHERE scores.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: